Moreover, a recent synthetic lethality screen uncovered 140 genes that have a synthetic growth defect with POLQ, most of which operate outside of DSB repair, and showed that as much as 30% of breast tumors may be relying on Pol θ for survival [13]. The gene discussed is POLQ; the disease is breast neoplasm.